COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 16:00, il y a 11 mois 1 jour Form 8.3 - Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose 0.04% interest in Avadel Pharmaceuticals plc as of 19th November 2025. No other party involved. No dealings reported Disclosure Dealings Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:55, il y a 11 mois 1 jour Original-Research: SFC Energy AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has updated its analysis on SFC Energy AG, lowering the price target to €21 and confirming the Buy recommendation. The Q3 results were weaker compared to the previous year First Berlin Equity Research Buy Recommendation Research Update SFC Energy AG Price Target
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:51, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.67% stake in Qualcomm Incorporated as of 19 November 2025. Purchase and sale of USD 0.0001 common shares The Vanguard Group Stake Disclosure Stock Transactions Investment Disclosure Qualcomm Incorporated
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:50, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as per Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure American Axle
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:48, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% position in JTC plc's 1p ordinary securities as of 19 November 2025 Position Disclosure The Vanguard Group 1p Ordinary Securities 5.05% JTC Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:46, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group discloses a 5.71% stake in Avadel Pharmaceuticals plc. Form 8.3 submitted to the Irish Takeover Panel on 20-Nov-2025 Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:45, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as per Form 8.3 to the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:44, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% stake in Greencore Group plc. Additional disclosure for Bakkavor Group plc. Purchase and sale details included Vanguard Group Stake Disclosure Purchase And Sale Greencore Group Plc Bakkavor Group Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:43, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses owning 1.23% of Bluefield Solar Income Fund Limited's ordinary securities as of 19 Nov 2025 Securities Vanguard Group Ownership Disclosure Financial Disclosure Bluefield Solar Income Fund
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:41, il y a 11 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc per Form 8.3. Details of securities dealt & positions held disclosed Securities The Vanguard Group, Inc. Form 8.3 Positions Spire Healthcare Group Plc
Publié le 21/10/2026 à 18:00, il y a 8 heures 49 minutes Saint-Gobain accélère sa croissance en Égypte avec l’ouverture de deux nouvelles capacités de production
Publié le 21/10/2026 à 18:00, il y a 8 heures 49 minutes Saint-Gobain accelerates its growth in Egypt with the opening of two new production capacities
Publié le 21/10/2026 à 17:59, il y a 8 heures 50 minutes Covivio Hotels - Revenus en hausse de +4,7 % à fin septembre 2026
Publié le 21/10/2026 à 17:59, il y a 8 heures 50 minutes Covivio Hotels : Revenues up +4.7% at end-September 2026
Publié le 21/10/2026 à 17:45, il y a 9 heures 4 minutes Covivio - Q3 2026 activity : Accelerating organic revenue growth supported by strong operational execution
Publié le 21/10/2026 à 22:00, il y a 4 heures 49 minutes Prospect Ridge Announces Second Tranche Closing of Critical Metals Flow-Through Unit Private Placement
Publié le 21/10/2026 à 15:00, il y a 11 heures 49 minutes Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Publié le 21/10/2026 à 14:40, il y a 12 heures 9 minutes Axo Metals Receives Approval to Trade on the OTCQB Venture Market Under the Symbol AXOCF
Publié le 21/10/2026 à 14:30, il y a 12 heures 19 minutes Fermi Provides Letter to Shareholders from CEO Lee McIntire on Financing Fermi's Next Chapter
Publié le 21/10/2026 à 14:00, il y a 12 heures 49 minutes Nine Mile Metals DDH WD-26-18 Intersects A High Grade VMS Lens, Returning 7.13% Cu-Eq Over 11.65 M Including 9.93% Cu-Eq Over 6.70 M And 10.46% Cu-Eq Over 4.80 M, With An Additional Upper 31.50m Copper Stringer Zone
Publié le 22/10/2026 à 00:00, il y a 2 heures 49 minutes EQS-Adhoc: Marley Spoon Group SE: Extension and increase of restructuring bridge financing for Marley Spoon SE
Publié le 21/10/2026 à 23:38, il y a 3 heures 11 minutes QIAGEN und EQT Private Equity geben Einigung über ein empfohlenes freiwilliges öffentliches Übernahmeangebot in bar bekannt
Publié le 21/10/2026 à 23:32, il y a 3 heures 17 minutes EQS-Adhoc: QIAGEN N.V.: Conclusion of a Business Combination Agreement with EQT Private Equity; preliminary Q3 2026 results and suspension of full-year 2026 outlook
Publié le 21/10/2026 à 23:30, il y a 3 heures 19 minutes EQS-WpÜG: Takeover Offer / Target company: Qiagen N.V.; Bidder: Crown NL Bidco B.V.
Publié le 21/10/2026 à 19:35, il y a 7 heures 14 minutes Leifheit Aktiengesellschaft: Leifheit revises its forecast for 2026 and accelerates the consistent implementation of the FOCUS performance program
